Showing results (461-470 of 844) with videos related to
Sort By:
Pageof 85
The New England Journal of Medicine|March 17, 1994
Evaluation of the quality of life associated with zidovudine treatment in asymptomatic human immunodeficiency virus infection. The AIDS Clinical Trials GroupW R Lenderking, R D Gelber, D J Cotton, et al.Bulletin of the World Health Organization|March 8, 2011
Management of diabetes and associated cardiovascular risk factors in seven countries: a comparison of data from national health examination surveysEmmanuela Gakidou, Leslie Mallinger, Jesse Abbott-Klafter, et al.Biogerontology|July 2, 2026
MSC-derived extracellular vesicles accelerate wound healing in senescent fibroblast culturesEkaterina Rudnitsky, Naomy Vineshtock, Natali Yakubov, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1996
Treatment of ovarian cancer with surgery, short-course chemotherapy and whole abdominal radiationK Buser, M Bacchi, A Goldhirsch, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 6, 2015
Tailoring therapies--improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015A S Coates, E P Winer, A Goldhirsch, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 29, 2006
Bisphosphonates and jaw osteonecrosis in patients with advanced breast cancerG Sanna, L Preda, R Bruschini, et al.Lancet (London, England)|September 18, 1999
Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study GroupR J Cote, H F Peterson, B Chaiwun, et al.The British Journal of Surgery|August 10, 2017
Improved prognosis of young patients with breast cancer undergoing breast-conserving surgeryE Botteri, P Veronesi, J Vila, et al.European Journal of Cancer (Oxford, England : 1990)|June 1, 1997
Formestane versus megestrol acetate in postmenopausal breast cancer patients after failure of tamoxifen: a phase III prospective randomised cross over trial of second-line hormonal treatment (SAKK 20/90). Swiss Group for Clinical Cancer Research (SAKK)B Thürlimann, M Castiglione, S F Hsu-Schmitz, et al.Cancer|September 26, 2001
A randomized, prospective trial of central venous ports connected to standard open-ended or Groshong catheters in adult oncology patientsR Biffi, F De Braud, F Orsi, et al.Pageof 85